期刊文献+

适形放疗与常规放疗结合治疗Ⅲ期肺鳞癌疗效分析 被引量:2

Analysis of efficacy of combination of conformal radiotherapy and routine radiotherapy in treatment of squamous cell cancer of lung
在线阅读 下载PDF
导出
摘要 目的探讨常规放疗与适形放疗结合治疗Ⅲ期肺鳞癌的疗效及患者的耐受性.方法自1996年10月至2002年10月对118例Ⅲ期肺鳞癌患者常规放射治疗40~50 Gy(平均44.6 Gy)后的残留病灶再行适形放疗.肿瘤边缘单次处方剂量平均为6.8 Gy,间隔1~2 d,总照射剂量平均为39.4 Gy.肿瘤靶体积(GTV)0.8~148.6 cm3,平均36.6 cm3;计划靶体积(PTV)3.6~213.5 cm3,平均51.4 cm3.结果近期CR率30.5%(36/118),PR率53.4%(63/118),NR率11.9%(14/118),PD率4.2%(5/118),总有效率(CR+PR)83.9%.1,2,3年生存率分别为68.6%(81/118)、35.6%(31/87)和12.2%(6/49),局部控制率分别为92.4%(109/118)、85.1%(74/87)和79.6%(39/49).急性放射性肺炎Ⅰ~Ⅱ级32例,Ⅲ级4例,Ⅳ级0例.晚期放射毒副反应:放射性食管损伤Ⅲ级1例,放射性肺损伤Ⅱ级1例.结论对Ⅲ期肺鳞癌常规放疗后再行适形放疗局部加量照射,患者可耐受,疗程短,可提高肿瘤控制率,延长生存期,是局部剂量升级的有效方法. Objective To evaluate the efficacy of combination of routine radiotherapy and 3-dimensional conformal radiotherapy (3-DCRT) in treatment of squamous cell cancer of lung at stage Ⅲ and the tolerance of the patients. Methods From Oct. 1996 to Oct. 2002,118 patients with squamous ceil cancer of lung at stage Ⅲ were treated with routine radiotherapy at the total doses of 40-50 Gy( average 44.6 Gy), The residues of these tumours were treated with 3-DCRT at single tumour target dose of 6.8 Gy every other or two days and a total dose of 39.4 Gy. The tumour target volume ranged from 0.8 to 148.6 cm3^ , with an average of 36.6 cm^3 . The planned target volume ranged from 3.6 to 213.5 cm^3 , with an average of 51.4 cm^3 . Results The short-term rate of CR was 30.5 % (36/118) ,PR 53.4%(63/118),NR 11.9%(14/118) and PD 4.2%(5/118).The response rate (CR+ PR) was 83.9%. 1-,2-,and 3-year survival rates were 68.6% (81/118),35.6% (31/87)and 12.2% (6/49)and local control rates were 92.4% (109/118), 85.1% (74/87) and 79,6% (39/49) respectively, The rates of acute radio-pneumonia were 27.1%(32/118) at grade- Ⅰ -Ⅱ ,3.4%(4/118)at grade Ⅲ and 0(0/118) at grade Ⅳ .The late side effects were the injury of esophagus at grade Ⅲ (1 case) and the injury of lung at grade Ⅱ ( 1 case). After the squamous ceil carcinoma of lung at stagem was treated with routine radiotherapy, the 3-DCRT could be used. The patients could tolerate this treatment. The period of the treatment was short. The control rate of the disease was raised and the survival time was prolonged, This treatment is the effective method for treating this disease.
出处 《中国肿瘤临床与康复》 2005年第4期358-360,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺肿瘤/放射疗法 三维适形放疗 Lung neoplasms/radiotherapy Three dimensional conformal radiotherapy
作者简介 季海涛(1975-),男,黑龙江呼兰人,医师,医学学士,从事肿瘤放疗与治疗研究。
  • 相关文献

参考文献4

二级参考文献14

  • 1[1]Dillman RO, Hemdon J, Seagren SL, et al. Improved survival in stage Ⅲ non- small cell lung cancer: seven- year follow- up of Cancer and Leukimia Group B (CALGB) 8433 trial[J] . J Natl Cancer Inst, 1996, 88:1210 - 1215.
  • 2[2]Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer. First analysis of a randomized trial in 353 patients[J]. J Natl Cancer Inst, 1991,83:417 - 423.
  • 3[3]Komaki R, Scott CB, Sause WT, et al. Induction cisplatin/vinblastine and irradiation vs. Irradiation in unresectable squamous cell lung cancer: Failure paterns bv cell type in RTOG 8808/ECOG 4588[J ] . Int J Radiat Oncol Biol Phys, 1997, 39:537 - 544.
  • 4[4]Schaake K C, van den Bogaert W, Dalesio 0, et al. Effects of concomitant cisplatin and radiation versus radiotherapy on inoperable non- small- cell lung cancer[J] . N Engl J Med,1992,326:524 - 530.
  • 5[5]Furuse K, Fukuoka M, Kawahara M, et al.phase Ⅲ study of concunent versus sequential thoracic radiotherapy in combination withmitomycin, vinblastine and cisplatin in unresectablestage Ⅲ non - small cell lung cancer[J] .J Clin Oncol, 1999,17:2692 - 2699.
  • 6[6]Curran W, Scott C, Langer C, et al. Phase Ⅲ comparison of sequential vs. Concurrent chemoradiation of pts with unresected stage Ⅲ non - small cell lung cancer (NSCLC) :initial report of Radiation Therapy Oncology Group (RTOG)9410.Pro. Am Soc Clin Oncol[J] .J Clin Oncol, 2000, 19(abstract 1891).
  • 7[7]Albain K, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage Ⅲ A(N2) and Ⅲ B non - small cell lung cancer: mature results of Southwest Oncology Group phase Ⅱ study 8805 [ J]. J Clin Oncol, 1995, 13: 1880- 1892.
  • 8[8]PORT Meta-analysis trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and metaanalysis of individual patient data from nine randomized controlled trials [J]. Lancet, 1998,352: 257 - 263.
  • 9[9]Dautzenberg B, Arriagada R, Chammard AB, et al.A controlled study of post - operative radiotherapy for completely resected non- small cell lung carcinoma[J] . Cancer, 1999, 86: 265 - 273.
  • 10[10]Emami B, Purdy JA, Manolis J, et al. Three - dimensional treatment planning for lung cancer[J] .Int J Radiat Oncol Biol Phys, 1991,21:217 - 227.

共引文献74

同被引文献32

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部